Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285956 · ClinicalTrials.gov registry record · NA
Feasibility of Calm to Reduce Stress and Improve Sleep During Pregnancy
A NA study, sponsored by Calm.com.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05285956: Clinical Trial NA study, sponsored by Calm.com.
NCT05285956 is a NA study that was terminated before completion, run by Calm.com. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05285956, a NA study, was terminated before completion, sponsored by Calm.com.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Purpose: Test the effects of using Calm for its impact on stress, anxiety, and sleep in pregnant women using the following aims: Aim #1: Determine the feasibility of using Calm. Aim #2: Determine the preliminary efficacy of using Calm on stress, anxiety, and sleep. Exploratory Aim #3: Explore the preliminary efficacy of using Calm on self-reported birth outcomes
Interventions
- BEHAVIORAL Calm app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05285956
The ClinicalTrials.gov registry entry for NCT05285956 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Calm.com, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calm app is the first listed.
NCT05285956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05285956 about?
NCT05285956 is a clinical study titled "Feasibility of Calm to Reduce Stress and Improve Sleep During Pregnancy". Purpose: Test the effects of using Calm for its impact on stress, anxiety, and sleep in pregnant women using the following aims: Aim #1: Determine the feasibility of using Calm. Aim #2: Determine the preliminary efficacy of using Calm on stress, anxiety, and sleep. Exploratory Aim #3: Explore the...
What is the current status of trial NCT05285956?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2022-03-01. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT05285956?
The interventions under investigation include: Calm app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05285956?
This trial is sponsored by Calm.com, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.